Insmed, Inc. (INSM)
177.88
+0.46
(+0.26%)
USD |
NASDAQ |
Dec 26, 16:00
177.15
-0.73
(-0.41%)
Pre-Market: 09:27
Insmed Shareholders Equity (Quarterly): 945.57M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 233.89M |
| Biogen, Inc. | 18.21B |
| Pfizer Inc. | 92.80B |
| Nektar Therapeutics | 85.09M |
| CorMedix, Inc. | 374.13M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.361B |
| Total Liabilities (Quarterly) | 1.415B |
| Debt to Equity Ratio | 0.788 |
| Current Ratio | 4.630 |
| Net Debt Paydown Yield | 0.41% |